Singular Genomics Revenue and Competitors

Claim your profile



Growjo Ranking



Estimated Revenue & Valuation

  • Singular Genomics's estimated annual revenue is currently $38.1M per year.(i)
  • Singular Genomics's estimated revenue per employee is $157,562
  • Singular Genomics's current valuation is $559.2M. (January 2022}

Employee Data

  • Singular Genomics has 242 Employees.(i)
  • Singular Genomics grew their employee count by 51% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation

Singular Genomics is a venture capital backed biotech company in La Jolla, California. We foster a dynamic, fast paced, result oriented environment where we offer employees the opportunity to make a significant impact in a rapidly expanding company. Singular Genomics is inventing at the forefront of genomics, one of the world?s fastest growing industries. We are located in the center of the Biotech hub on the Torrey Mesa close to the Pacific Ocean and next door to prestigious institutions like the Salk Institute, Scripps, Sanford Burnham, and UCSD. We offer free gym membership, 401K plan, competitive health benefits, flexible vacation, and equity incentives, so you can grow as the company grows. We are working to accelerate genomics for the advancement of science and medicine and are passionate about the potential of genomics for improving human health.



Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Singular Genomics News

2022-04-13 - Singular Genomics Systems, Inc. (NASDAQ:OMIC) Short ...

Singular Genomics Systems, Inc, a life science technology company, develops next generation sequencing and multiomics technology to build...

2022-04-13 - Reviewing Singular Genomics Systems (NASDAQ:OMIC) and ...

Reviewing Singular Genomics Systems (NASDAQ:OMIC) and Cytek Biosciences (NASDAQ:CTKB). Posted by admin on Apr 14th, 2022.

2022-03-30 - NGS Upstarts Expected to Take On the Champion

Founded in 2016, Singular Genomics develops sequencing instruments that incorporate the company's proprietary sequencing-by-synthesis chemistry.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding